Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives
Cancer is considered as one of the most serious health problems today. The discovery of
nitrogen mustard as an alkylating agent in 1942, opened a new era in the cancer …
nitrogen mustard as an alkylating agent in 1942, opened a new era in the cancer …
Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines
RJ Turesky, L Le Marchand - Chemical research in toxicology, 2011 - ACS Publications
Aromatic amines and heterocyclic aromatic amines (HAAs) are structurally related classes of
carcinogens that are formed during the combustion of tobacco or during the high …
carcinogens that are formed during the combustion of tobacco or during the high …
Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution.
MA Watson, RK Stewart, GB Smith, TE Massey… - …, 1998 - academic.oup.com
The association between glutathione S-transferase (GST) activity as measured by 1-chloro-
2, 4-dinitrobenzene (CDNB) conjugation and genotype at exon 5 and exon 6 of the human …
2, 4-dinitrobenzene (CDNB) conjugation and genotype at exon 5 and exon 6 of the human …
Glutathione transferases and cancer
S Tsuchida, K Sato - Critical reviews in biochemistry and molecular …, 1992 - Taylor & Francis
The glutathione transferases, a family of multifunctional proteins, catalyze the glutathione
conjugation reaction with electrophilic compounds biotransformed from xenobiotics …
conjugation reaction with electrophilic compounds biotransformed from xenobiotics …
Association Between Glutathione S-Transferase P1, T1, and M1 Genetic Polymorphism and Survival of Patients With Metastatic Colorectal Cancer
J Stoehlmacher, DJ Park, W Zhang… - Journal of the …, 2002 - academic.oup.com
Background: Members of the glutathione S-transferase (GST) superfamily are important in
cellular defense mechanisms. These enzymes attach reduced glutathione to electrophilic …
cellular defense mechanisms. These enzymes attach reduced glutathione to electrophilic …
Drug-metabolizing enzymes mechanisms and functions
SA Sheweita - Current drug metabolism, 2000 - ingentaconnect.com
Drug-metabolizing enzymes are called mixed-function oxidase or monooxygenase and
containing many enzymes including cytochrome P450, cytochrome b5, and NADPH …
containing many enzymes including cytochrome P450, cytochrome b5, and NADPH …
Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases
CJ Henderson, AG Smith, J Ure… - Proceedings of the …, 1998 - National Acad Sciences
The activity of chemical carcinogens is a complex balance between metabolic activation by
cytochrome P450 monooxygenases and detoxification by enzymes such as glutathione S …
cytochrome P450 monooxygenases and detoxification by enzymes such as glutathione S …
Urinary metabonomic study on colorectal cancer
After our serum metabonomic study of colorectal cancer (CRC) patients recently published
in J. Proteome Res., we profiled urine metabolites from the same group of CRC patients …
in J. Proteome Res., we profiled urine metabolites from the same group of CRC patients …
A GSTP1-mediated lactic acid signaling promotes tumorigenesis through the PPP oxidative branch
Lactic acidosis is a feature of solid tumors and plays fundamental role (s) rendering cancer
cells to adapt to diverse metabolic stresses, but the mechanism underlying its roles in redox …
cells to adapt to diverse metabolic stresses, but the mechanism underlying its roles in redox …
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy
A Ruzzo, F Graziano, F Loupakis, E Rulli… - Journal of clinical …, 2007 - ascopubs.org
Purpose The objective is to investigate whether polymorphisms with putative influence on
fluorouracil/oxaliplatin activity are associated with clinical outcomes of patients with …
fluorouracil/oxaliplatin activity are associated with clinical outcomes of patients with …